The meta-analysis of 25 case–control studies indicated that XRCC1 Arg194Trp polymorphism is not associated with lung cancer risk within human populations, and subgroup analysis upon source of controls, ethnicity, and HWE for controls is consistent with this result, which was also supported by cumulative meta-analysis and sensitivity analysis. Here, XRCC1 is linked to lung carcinoma.